Radiochemotherapy in head and neck cancer.
The present paper is based on a talk given, during the meeting of the EORTC Radiotherapy Group, held in Arona (Italy) on April 19-20, 2002. This review analyses many still open questions on combined chemotherapy and radiotherapy in head and neck cancer, on the basis of the available data. The paper may help to point out future directions for novel clinical researches on combined chemotherapy and radiotherapy in head and neck cancer.
Merlano
Marco
M
Medical Oncology Unit, Department of Clinical Oncology, St. Croce General Hospital, 26 Via M. Coppino, Cuneo, 12100, Italy.
Marchetti
Giuseppe
G
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D019583:Dose Fractionation, Radiation; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D018579:Patient Selection; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use; D018714:Radiotherapy, Adjuvant; D016019:Survival Analysis; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D011838:Radiation-Sensitizing Agents